These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 7406481)

  • 21. Safety, Tolerability, Pharmacokinetics, and Drug Interaction Potential of SPR741, an Intravenous Potentiator, after Single and Multiple Ascending Doses and When Combined with β-Lactam Antibiotics in Healthy Subjects.
    Eckburg PB; Lister T; Walpole S; Keutzer T; Utley L; Tomayko J; Kopp E; Farinola N; Coleman S
    Antimicrob Agents Chemother; 2019 Sep; 63(9):. PubMed ID: 31262767
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Kinetics and mechanism of in vitro uptake of amino-beta-lactam antibiotics by rat small intestine and relation to the intact-peptide transport system.
    Nakashima E; Tsuji A; Mizuo H; Yamana T
    Biochem Pharmacol; 1984 Nov; 33(21):3345-52. PubMed ID: 6497897
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dose-dependent absorption and elimination of cefadroxil in man.
    Garrigues TM; Martin U; Peris-Ribera JE; Prescott LF
    Eur J Clin Pharmacol; 1991; 41(2):179-83. PubMed ID: 1743250
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetics of oral cephalosporins: cephradine cephalexin.
    Finkelstein E; Quintiliani R; Lee R; Bracci A; Nightingale CH
    J Pharm Sci; 1978 Oct; 67(10):1447-50. PubMed ID: 702300
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cefaclor uptake by the proton-dependent dipeptide transport carrier of human intestinal Caco-2 cells and comparison to cephalexin uptake.
    Dantzig AH; Tabas LB; Bergin L
    Biochim Biophys Acta; 1992 Dec; 1112(2):167-73. PubMed ID: 1457450
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative human oral clinical pharmacology of cefadroxil, cephalexin, and cephradine.
    Pfeffer M; Jackson A; Ximenes J; de Menezes JP
    Antimicrob Agents Chemother; 1977 Feb; 11(2):331-8. PubMed ID: 848940
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cefatrizine (SK&F 60771), a new oral cephalosporin: serum levels and urinary recovery in humans after oral or intramuscular administration--comparative study with cephalexin and cefazolin.
    Actor P; Pitkin DH; Lucyszyn G; Weisbach JA; Bran JL
    Antimicrob Agents Chemother; 1976 May; 9(5):800-3. PubMed ID: 949177
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A pharmacokinetic comparison of cefadroxil and cephalexin after administration of 250, 500 and 1000 mg solution doses.
    Barbhaiya RH
    Biopharm Drug Dispos; 1996 May; 17(4):319-30. PubMed ID: 8743403
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phosphonopeptides as substrates for peptide transport systems and peptidases of Escherichia coli.
    Atherton FR; Hall MJ; Hassall CH; Lambert RW; Lloyd WJ; Lord AV; Ringrose PS; Westmacott D
    Antimicrob Agents Chemother; 1983 Oct; 24(4):522-8. PubMed ID: 6360039
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetics of cephalothin and cephalexin in selected avian species.
    Bush M; Locke D; Neal LA; Carpenter JW
    Am J Vet Res; 1981 Jun; 42(6):1014-7. PubMed ID: 7283231
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro antimicrobial activity and human pharmacology of cephalexin, a new orally absorbed cephalosporin C antibiotic.
    Thornhill TS; Levison ME; Johnson WD; Kaye D
    Appl Microbiol; 1969 Mar; 17(3):457-61. PubMed ID: 4388601
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 99mTc-alafosfalin: an antibiotic peptide infection imaging agent.
    Tsopelas C; Penglis S; Ruszkiewicz A; Bartholomeusz FD
    Nucl Med Biol; 2003 Feb; 30(2):169-75. PubMed ID: 12623116
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rufinamide: clinical pharmacokinetics and concentration-response relationships in patients with epilepsy.
    Perucca E; Cloyd J; Critchley D; Fuseau E
    Epilepsia; 2008 Jul; 49(7):1123-41. PubMed ID: 18503564
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cephalexin in the therapy of infections of the urinary tract.
    Weinstein AJ
    Postgrad Med J; 1983; 59 Suppl 5():40-2. PubMed ID: 6664942
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Selectivity of the cimetidine-induced alterations in the renal handling of organic substrates in humans. Studies with anionic, cationic and zwitterionic drugs.
    van Crugten J; Bochner F; Keal J; Somogyi A
    J Pharmacol Exp Ther; 1986 Feb; 236(2):481-7. PubMed ID: 3944769
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Comparative pharmacokinetics of oral cephalosporins: cephalexin, cefaclor and cefadroxil (author's transl)].
    Lode H; Stahlmann R; Dzwillo G; Koeppe P
    Arzneimittelforschung; 1980; 30(3):505-9. PubMed ID: 7387765
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phosphonopeptides Revisited, in an Era of Increasing Antimicrobial Resistance.
    Marrs ECL; Varadi L; Bedernjak AF; Day KM; Gray M; Jones AL; Cummings SP; Anderson RJ; Perry JD
    Molecules; 2020 Mar; 25(6):. PubMed ID: 32210055
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effective prophylaxis of recurrent urinary tract infections in premenopausal women by postcoital administration of cephalexin.
    Pfau A; Sacks TG
    J Urol; 1989 Nov; 142(5):1276-8. PubMed ID: 2810506
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetic comparison between fosfomycin and other phosphonic acid derivatives.
    Bergan T
    Chemotherapy; 1990; 36 Suppl 1():10-8. PubMed ID: 2085981
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cefadroxil. A review of its antibacterial, pharmacokinetic and therapeutic properties in comparison with cephalexin and cephradine.
    Tanrisever B; Santella PJ
    Drugs; 1986; 32 Suppl 3():1-16. PubMed ID: 3542485
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.